Wednesday, October 14, 2026

88% of Executives Regret Rushing Into Agentic AI Before Governance Was Ready

The Agentic Enterprise Report 2026 reveals 88% of executives wish they had done deeper foundational work before adopting agentic AI, while 42% of companies still lack clear internal accountability for AI initiatives. Enterprise infrastructure — GPU clusters, exascale storage, agentic platforms — has reached production maturity. Organizational governance has not.

LM Salvado
LM Salvado

June 15, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
88% of Executives Regret Rushing Into Agentic AI Before Governance Was Ready
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

88% of executives wish they had done deeper foundational work before adopting agentic AI, according to the Agentic Enterprise Report 2026.1 42% of companies still lack clear internal accountability for AI initiatives.1 The infrastructure is ready. The organizations are not.

H2 2026 marks a convergence point. NVIDIA GPU acceleration, Dell Exascale Storage, and AMD MI350P chips are in production. Snowflake's CoCo platform — now used by Fanatics, Thomson Reuters, and WHOOP — provides a governed control plane for enterprise AI workflows.2 AppFolio's Performer and sector-specific vertical agents are hitting enterprise deployments simultaneously. The hardware and software layers have arrived together. The accountability layer has not.

"Your existing tech stack was designed for human-operated, application-centric workflows," Surojit Chatterjee of Ema wrote in MIT Technology Review. "It needs to be reconsidered when the actor is an AI agent operating at machine speed across multiple systems simultaneously."3

The problem is categorical, not incremental. Chatterjee argues that labels like "digital transformation" or "co-pilot" fail to capture what AI Business Transformation (ABT) actually requires. ABT means integrating agents into the fabric of the organization — redesigning operating models, workforce structures, and accountability chains wholesale.

Prasun Shah, also writing in MIT Technology Review, frames AI agents not as another software layer but as "connective tissue" that moves across layers to coordinate tasks and contextualize data from multiple applications.3 That cross-system mobility is the competitive advantage — and the governance liability.

For finance and enterprise risk teams, the accountability gap is concrete. When an AI agent executes transactions, synthesizes regulatory filings, or approves procurement workflows across multiple systems simultaneously, the question of error ownership becomes a legal and compliance issue — not a technology one. Existing frameworks were written for human actors operating at human speed.

The structural fix requires more than updated policy documents. Companies need to assign named owners for AI initiatives, define escalation paths for agent errors, and maintain auditable decision trails the way they do for human employees. Most have not started.

Infrastructure maturity without governance maturity creates liability. The executives already behind know it.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]Press releaseGlobeNewswire· June 9, 2026
    Contentstack stellt seine „Agentic Experience Platform“ (AXP) mit „Agent OS“ und „Agent Accelerator“ vor, um Hindernisse für den ROI und die Einführung von KI in Unternehmen zu beseitigen
  2. [2]News articleYahoo Finance· May 26, 2026
    Factory Announces Madison Faulkner as Head of Strategy and Welcomes AI Veteran and NEA Partner, Lila Tretikov to Board
  3. [3]News articleMIT Technology Review
    Rethinking organizational design in the age of agentic AI
  4. [4]News articleYahoo Finance· June 2, 2026
    Snowflake CoCo Redefines Enterprise AI Development as the Coding Agent Built for Faster, Easier, and More Powerful Innovation Anywhere
  5. [5]News articleMIT Technology Review
    The Download: whole-body rejuvenation drugs and five things to know about AI
  6. [6]News articleYahoo Finance· May 20, 2026
    AMD MI350P PCIe GPUs Extend AI Reach Into Enterprise Data Centers
  7. [7]News articleYahoo Finance· April 22, 2026
    AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER
  8. [8]Press releaseGlobeNewswire· March 24, 2026
    Cloudera Membawa Era Awan di Mana Saja ke Persidangan Tahunan Global Data dan AI, EVOLVE26
  9. [9]News articleYahoo Finance· March 16, 2026
    Dell AI Data Platform with NVIDIA Supercharges Enterprise AI with Breakthrough Data Orchestration and Storage Innovations
  10. [10]News articleIEEE Spectrum
    How Melbourne’s AI and Data Center Flywheel Is Accelerating Research Innovation
  11. [11]News articleSeeking Alpha· June 9, 2026
    SailPoint outlines FY2027 revenue of $1.27B and 19% adjusted operating margin as agentic pipeline doubled in Q1
  12. [12]News articleYahoo Finance· April 19, 2026
    STT Q1 Deep Dive: Fee Revenue, Digital Innovation, and AI Transformation Propel Results

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com